name:-0.076297998428345
name:-0.10336399078369
name:-0.014359951019287
The McLean Hospital Corporation Patent Filings

The McLean Hospital Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for The McLean Hospital Corporation.The latest application filed is for "autologous cell replacement therapy for parkinson`s disease".

Company Profile
13.109.81
  • The McLean Hospital Corporation - Belmont MA US
  • The McLean Hospital Corporation - Blemont MA US
  • MCLEAN HOSPITAL CORPORATION -
  • The McLean Hospital Corporation - Boston MA
  • The Mclean Hospital Corporation - 115 Mill street Belmont US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Autologous Cell Replacement Therapy For Parkinson`s Disease
App 20220243174 - KIM; Kwang-Soo
2022-08-04
Aminoquinoline Derivatives and Uses Thereof
App 20220008418 - Rawat; Diwan S. ;   et al.
2022-01-13
Generation of Post-Mitotic Migratory Cortical Interneurons
App 20210340502 - Chung; Sangmi
2021-11-04
Synergistic Genome-Nonintegrating Reprogramming by Micrornas and Transcription Factors
App 20210238556 - Kim; Kwang-Soo ;   et al.
2021-08-05
Aminoquinoline derivatives and uses thereof
Grant 11,026,943 - Rawat , et al. June 8, 2
2021-06-08
Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors
Grant 11,001,809 - Kim , et al. May 11, 2
2021-05-11
Glucocerebrosidase gene therapy for Parkinson's disease
Grant 10,967,073 - Park , et al. April 6, 2
2021-04-06
System and method for tracking cerebral blood flow in fMRI
Grant 10,912,470 - Tong , et al. February 9, 2
2021-02-09
Methods And Compositions For Mitochondrial Replacement Therapy
App 20200316115 - Cataldo; Anne M. ;   et al.
2020-10-08
Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease
Grant 10,787,669 - Hastings , et al. September 29, 2
2020-09-29
Systems and methods for modeling and predicting effective treatments for schizophrenia and other disorders
Grant 10,720,242 - Siekmeier
2020-07-21
METHODS AND COMPOSITIONS RELATED TO THE TREATMENT OF NURR1- AND PPARy-MEDIATED CONDITIONS
App 20200206309 - Kim; Kwang-Soo ;   et al.
2020-07-02
Methods For Manipulating Cell Fate
App 20190376046 - Kim; Kwang-Soo
2019-12-12
Antisense Compounds Targeting Leucine-Rich Repeat Kinase 2(LRRK2) For The Treatment of Parkinsons Disease
App 20190309304 - Hastings; Michelle L. ;   et al.
2019-10-10
Magnetic field stimulation
Grant 10,426,969 - Rohan October 1, 2
2019-10-01
Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
Grant 10,370,667 - Hastings , et al.
2019-08-06
System and method for evaluation of circulatory function
Grant 10,201,314 - Frederick , et al. Feb
2019-02-12
Methods And Compositions For The Prevention Of Suicide, Homicide And Self-harming Behaviors
App 20180318338 - MELONI; Edward G.
2018-11-08
Multi-modal imaging of blood flow
Grant 10,085,642 - Frederick , et al. October 2, 2
2018-10-02
2-alkoxy-11-hydroxyaporphine derivatives and uses thereof
Grant 10,081,600 - Neumeyer , et al. September 25, 2
2018-09-25
Methods And Compositions For The Treatment Or Prevention Of Parkinson's Disease
App 20180243343 - Isacson; Ole
2018-08-30
Glucocerebrosidase Gene Therapy For Parkinson's Disease
App 20180147300 - Park; Yung Hee ;   et al.
2018-05-31
Dopaminergic neurons differentiated from pluripotent stem cells and uses thereof
Grant 9,968,637 - Cooper , et al. May 15, 2
2018-05-15
Antisense Compounds Targeting Leucine-Rich Repeat Kinase 2 (LRRK2) For The Treatment Of Parkinsons Disease
App 20180094266 - HASTINGS; Michelle L. ;   et al.
2018-04-05
Methods And Compositions For Mitochondrial Replacement Therapy
App 20180071337 - CATALDO (Deceased); Anne M. ;   et al.
2018-03-15
Methods and compositions for mitochondrial replacement therapy
Grant 9,855,296 - Cataldo , et al. January 2, 2
2018-01-02
Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
Grant 9,840,710 - Hastings , et al. December 12, 2
2017-12-12
Magnetic Field Stimulation
App 20170340894 - Rohan; Michael
2017-11-30
Xenon And/or Argon Treatment As An Adjunct To Psychotherapy For Psychiatric Disorders
App 20170312308 - Meloni; Edward G. ;   et al.
2017-11-02
Methods for purifying midbrain dopaminergic neural progenitor cells
Grant 9,750,768 - Kim , et al. September 5, 2
2017-09-05
Magnetic field stimulation
Grant 9,737,726 - Rohan August 22, 2
2017-08-22
Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders
Grant 9,737,562 - Meloni , et al. August 22, 2
2017-08-22
Aminoquinoline Derivatives And Uses Thereof
App 20170209441 - RAWAT; Diwan S. ;   et al.
2017-07-27
2-alkoxy-11-hydroxyaporphine Derivatives And Uses Thereof
App 20170166531 - NEUMEYER; John L. ;   et al.
2017-06-15
Method for convection enhanced therapeutic delivery
Grant 9,662,472 - Cunningham May 30, 2
2017-05-30
Antisense Compounds Targeting Leucine-Rich Repeat Kinase 2 (LRRK2) For The Treatment Of Parkinsons Disease
App 20170137826 - Hastings; Michelle L. ;   et al.
2017-05-18
Methods And Compositions For Mitochondrial Replacement Therapy
App 20170065635 - CATALDO; Anne M. ;   et al.
2017-03-09
Aminoquinoline derivatives and uses thereof
Grant 9,567,316 - Rawat , et al. February 14, 2
2017-02-14
2-alkoxy-11-hydroxyaporphine derivatives and uses thereof
Grant 9,517,279 - Neumeyer , et al. December 13, 2
2016-12-13
Synergistic Genome-nonintegrating Reprogramming By Micrornas And Transcription Factors
App 20160298089 - KIM; Kwang-Soo ;   et al.
2016-10-13
System And Method For Tracking Cerebral Blood Flow In Fmri
App 20160287100 - Tong; Yunjie ;   et al.
2016-10-06
METHODS FOR EFFICIENT GENERATION OF GABAergic INTERNEURONS FROM PLURIPOTENT STEM CELLS
App 20160272940 - CHUNG; Sangmi
2016-09-22
Multipotent Neural Cells
App 20160095887 - Isacson; Ole ;   et al.
2016-04-07
Methods For Measuring The Magnitude Of Attention And Motor Activity Disturbance In A Subject
App 20160066830 - TEICHER; Martin H.
2016-03-10
Methods for isolating early neurons and neuroblasts
Grant 9,249,389 - Isacson , et al. February 2, 2
2016-02-02
Magnetic Field Treatment Techniques
App 20160001074 - Rohan; Michael L. ;   et al.
2016-01-07
Xenon And/or Argon Treatment As An Adjunct To Psychotherapy For Psychiatric Disorders
App 20150306136 - MELONI; Edward G. ;   et al.
2015-10-29
Dopaminergic Neurons Differentiated From Pluripotent Stem Cells And Uses Thereof
App 20150250825 - Cooper; Oliver ;   et al.
2015-09-10
Methods for measuring the magnitude of attention and motor activity disturbance in a subject
Grant 9,050,032 - Teicher June 9, 2
2015-06-09
Drug-Enhanced Neurofeedback
App 20150150473 - Knight; Elizabeth Quattrocki ;   et al.
2015-06-04
Method for diagnosing ADHD and related behavioral disorders
Grant 9,005,142 - Teicher , et al. April 14, 2
2015-04-14
Aminoquinoline Derivatives And Uses Thereof
App 20150023930 - Rawat; Diwan S. ;   et al.
2015-01-22
Method For Convection Enhanced Therapeutic Delivery
App 20140243781 - Cunningham; Miles G.
2014-08-28
Neuronal Progenitor Cells And Uses
App 20140199274 - Kim; Kwang-Soo ;   et al.
2014-07-17
Apparatus and method for convection enhanced therapeutic delivery
Grant 8,715,240 - Cunningham May 6, 2
2014-05-06
Magnetic field treatment techniques
Grant 8,702,582 - Rohan , et al. April 22, 2
2014-04-22
Multipotent Neural Cells
App 20140087464 - Isacson; Ole ;   et al.
2014-03-27
Neural Stem Cells Derived From Induced Pluripotent Stem Cells
App 20140065227 - Isacson; Ole ;   et al.
2014-03-06
Method For Diagnosing Adhd And Related Behavioral Disorders
App 20140058290 - Teicher; Martin H. ;   et al.
2014-02-27
Treating Schizophrenia
App 20130331394 - Siekmeier; Peter
2013-12-12
RAB3B for treatment and prevention of Parkinson's disease
Grant 8,586,558 - Isacson , et al. November 19, 2
2013-11-19
Treatment of sequelae of psychiatric disorders
Grant 8,551,986 - Elman , et al. October 8, 2
2013-10-08
Prevention And Treatment Of Diseases Characterized By Mesencephalic Dopaminergic Neuron Cell Death
App 20130261165 - Isacson; Ole ;   et al.
2013-10-03
G-substrate for the treatment and prevention of parkinson's disease
Grant 8,545,834 - Isacson , et al. October 1, 2
2013-10-01
Methods And Kits For Treating Cluster Headache Disorders
App 20130252996 - HALPERN; John H. ;   et al.
2013-09-26
Use of secretin in treatments of disorders associated with the amygdala
Grant 8,524,665 - Yurgelun-Todd , et al. September 3, 2
2013-09-03
2-alkoxy-11-hydroxyaporphine Derivatives And Uses Thereof
App 20130209362 - Neumeyer; John L. ;   et al.
2013-08-15
Salvinorin derivatives and uses thereof
Grant 8,492,564 - Beguin , et al. July 23, 2
2013-07-23
Method for diagnosing ADHD and related behavioral disorders
Grant 8,469,901 - Teicher , et al. June 25, 2
2013-06-25
Multi-modal Imaging Of Blood Flow
App 20130144140 - Frederick; Blaise ;   et al.
2013-06-06
Dopaminergic Neurons Differentiated From Pluripotent Stem Cells And Uses Of Thereof
App 20130108669 - Cooper; Oliver ;   et al.
2013-05-02
Method for assessing auditory attention and vigilance
Grant 8,430,672 - Teicher , et al. April 30, 2
2013-04-30
R(-)-2-methoxy-11-hydroxyaporphine and derivatives thereof
Grant 8,431,591 - Neumeyer , et al. April 30, 2
2013-04-30
Methods and kits for treating cluster headache disorders
Grant 8,415,371 - Halpern , et al. April 9, 2
2013-04-09
Magnetic Field Treatment Techniques
App 20130066138 - Rohan; Michael L. ;   et al.
2013-03-14
Compositions And Methods For Treatment Of Parkinson's Disease
App 20130052268 - Chung; Sangmi ;   et al.
2013-02-28
Method For Diagnosing Adhd And Related Behavioral Disorders
App 20120310117 - Teicher; Martin H. ;   et al.
2012-12-06
Magnetic field treatment techniques
Grant 8,303,480 - Rohan , et al. November 6, 2
2012-11-06
Induced Pluripotent Stem Cells
App 20120128655 - Kim; Dohoon ;   et al.
2012-05-24
Methods and compositions for the treatment of medical disorders
Grant 8,168,169 - Cataldo , et al. May 1, 2
2012-05-01
Methods for diagnosis and prognosis of psychotic disorders
Grant 8,163,475 - Konradi April 24, 2
2012-04-24
Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases
Grant 8,153,422 - Isacson , et al. April 10, 2
2012-04-10
Methods and compositions for the treatment of Parkinson's Disease
Grant 8,114,892 - Kim , et al. February 14, 2
2012-02-14
Magnetic Field Treatment Techniques
App 20120022315 - Rohan; Michael L. ;   et al.
2012-01-26
Salvinorin Derivatives And Uses Thereof
App 20120010219 - Beguin; Cecile ;   et al.
2012-01-12
Computerized methods for evaluating response latency and accuracy in the diagnosis of attention deficit hyperactivity disorder
Grant 8,078,253 - Teicher , et al. December 13, 2
2011-12-13
Methods And Systems For Drug Screening And Computational Modeling Based On Biologically Realistic Neurons
App 20110301856 - Siekmeier; Peter ;   et al.
2011-12-08
R(-)-11-hydroxyaporphine derivatives and uses thereof
Grant 8,063,060 - Neumeyer , et al. November 22, 2
2011-11-22
Magnetic field treatment techniques
Grant 8,047,979 - Rohan , et al. November 1, 2
2011-11-01
Drug-Enhanced Neurofeedback
App 20110263968 - Quattrocki-Knight; Elizabeth ;   et al.
2011-10-27
Compounds for the treatment of psychiatric or substance abuse disorders
Grant 8,030,294 - Renshaw October 4, 2
2011-10-04
Method And Apparatus For Identifying A Safe And Efficacious Dosing Regimen
App 20110208437 - Teicher; Martin
2011-08-25
Methods For Measuring The Magnitude Of Attention And Motor Activity Disturbance In A Subject
App 20110208439 - Teicher; Martin H.
2011-08-25
Multipotent Neural Cells
App 20110135696 - Isacson; Ole ;   et al.
2011-06-09
Compounds for the treatment of marihuana dependence, withdrawal, and usage
Grant 7,947,661 - Lukas , et al. May 24, 2
2011-05-24
Methods and systems for drug screening and computational modeling based on biologically realistic neurons
Grant 7,945,392 - Siekmeier , et al. May 17, 2
2011-05-17
Method for determining fluctuation in attentional state and overall attentional state
Grant 7,942,828 - Teicher , et al. May 17, 2
2011-05-17
Methods And Kits For Treating Cluster Headache Disorders
App 20110104275 - Halpern; John H. ;   et al.
2011-05-05
Treatment Of Impulse Control Disorders
App 20110046120 - Elman; Igor
2011-02-24
R(-)-2-methoxy-11-hydroxyaporphine And Derivatives Thereof
App 20110034446 - Neumeyer; John L. ;   et al.
2011-02-10
Methods for the treatment of mood disorders
Grant 7,884,077 - Cohen , et al. February 8, 2
2011-02-08
Methods And Compositions For Mitochondrial Replacement Therapy
App 20110008310 - Cataldo; Anne M. ;   et al.
2011-01-13
Compounds for the treatment of psychiatric or substance abuse disorders
Grant 7,863,254 - Renshaw January 4, 2
2011-01-04
CNS assay for prediction of therapeutic efficacy for neuropathic pain and other functional illnesses
Grant 7,860,552 - Borsook , et al. December 28, 2
2010-12-28
Diagnosis of attention deficit hyperactivity disorder
Grant 7,807,362 - Kim , et al. October 5, 2
2010-10-05
Pyrimidines, Such As Uridine, In Treatments For Patients With Bipolar Disorder
App 20100222296 - Renshaw; Perry
2010-09-02
Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
Grant 7,737,128 - Renshaw June 15, 2
2010-06-15
R(-)-11-hydroxyaporphine Derivatives And Uses Thereof
App 20100081651 - Neumeyer; John L. ;   et al.
2010-04-01
Corticosteroid Conjugates And Uses Thereof
App 20100056488 - Teicher; Martin H. ;   et al.
2010-03-04
R(--)-11-hydroxyaporphine derivatives and uses thereof
Grant 7,648,995 - Neumeyer , et al. January 19, 2
2010-01-19
Salvinorin derivatives and uses thereof
Grant 7,629,475 - Bequin , et al. December 8, 2
2009-12-08
Compounds for the treatment of tobacco dependence and withdrawal
Grant 7,601,701 - Lukas October 13, 2
2009-10-13
Multimerized enhancer domains for cell-specific expression
Grant 7,585,962 - Kim , et al. September 8, 2
2009-09-08
Methods for the Treatment of ADHD and Related Disorders
App 20090221552 - Teicher; Martin ;   et al.
2009-09-03
Method For Assessing Auditory Attention And Vigilance
App 20090202966 - Teicher; Martin H. ;   et al.
2009-08-13
Inter-subject coherence in DT-MRI
Grant 7,570,049 - Lange August 4, 2
2009-08-04
Pyrimidines, Such As Uridine, In Treatments For Patients With Bipolar Disorder
App 20090054370 - Renshaw; Perry
2009-02-26
Methods for the treatment of mood disorders
App 20090048177 - Cohen; Bruce M. ;   et al.
2009-02-19
Apparatus and Method for Convection Enhanced Therapeutic Delivery
App 20080287917 - Cunningham; Miles G.
2008-11-20
Dopominergic Neurons Differentiated From Embryonic Cells For Treating Neurodegenerative Diseases
App 20080274548 - Isacson; Ole ;   et al.
2008-11-06
Methods for diagnosis and prognosis of psychotic disorders
App 20080009010 - Konradi; Christine
2008-01-10
Treatment of cocaine abuse using N-substituted derivatives of morphinan
Grant 7,291,628 - Neumeyer , et al. November 6, 2
2007-11-06
Magnetic field stimulation techniques
Grant 7,282,021 - Rohan , et al. October 16, 2
2007-10-16
Mixed kappa/mu opioids and uses thereof
Grant 7,271,173 - Neumeyer , et al. September 18, 2
2007-09-18
Inter-subject coherence in DT-MRI
Grant 7,268,551 - Lange September 11, 2
2007-09-11
Methods for identifying anatomical and molecular targets for analgesic therapy
App 20060253014 - Borsook; David ;   et al.
2006-11-09
Compounds for the treatment of tobacco dependence and withdrawal
Grant 7,053,064 - Lukas May 30, 2
2006-05-30
Method and apparatus for determining attention deficit hyperactivity disorder (ADHD) medication dosage and for monitoring the effects of ADHD medication on people who have ADHD using complementary tests
Grant 7,037,260 - Keirsbilck , et al. May 2, 2
2006-05-02
Magnetic field stimulation techniques
Grant 7,033,312 - Rohan , et al. April 25, 2
2006-04-25
CNS assay for prediction of therapeutic efficacy for neuropathic pain and other functional illnesses
App 20060074298 - Borsook; David ;   et al.
2006-04-06
Magnetic resonance with stimulation
App 20060039856 - Cowan; Ronald ;   et al.
2006-02-23
Methods for diagnosing akathisia
Grant 6,994,670 - Teicher , et al. February 7, 2
2006-02-07
N-substituted derivatives of morphinan and uses thereof
App 20050159440 - Neumeyer, John L. ;   et al.
2005-07-21
Method for providing optimal drug dosage
Grant 6,898,455 - Anderson , et al. May 24, 2
2005-05-24
Generation of synthetic nuclear magnetic resonance signals
Grant 6,861,840 - Frederick , et al. March 1, 2
2005-03-01
Technique for diagnosing attention deficit hyperactivity disorder
Grant 6,843,774 - Foust , et al. January 18, 2
2005-01-18
N-substituted derivatives of morphinan and uses thereof
Grant 6,844,438 - Neumeyer , et al. January 18, 2
2005-01-18
Color magnetic resonance imaging
Grant 6,804,384 - Lowen October 12, 2
2004-10-12
Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder
Grant 6,747,029 - Baldessarini , et al. June 8, 2
2004-06-08
Technique for diagnosing attention deficit hyperactivity disorder using complimentary tests
Grant 6,746,409 - Keirsbilck , et al. June 8, 2
2004-06-08
Method for determining attention deficit hyperactivity disorder (ADHD) medication dosage and for monitoring the effects of (ADHD) medication
Grant 6,743,182 - Miller , et al. June 1, 2
2004-06-01
Method And Apparatus For Determining Attention Deficit Hyperactivity Disorder (adhd) Medication Dosage And For Monitoring The Effects Of Adhd Medication On People Who Have Adhd Using Complementary Tests
Grant 6,726,624 - Keirsbilck , et al. April 27, 2
2004-04-27
Method for determining fluctuation in attentional state and overall attentional state
Grant 6,685,652 - Teicher , et al. February 3, 2
2004-02-03
ADHD detection by eye saccades
Grant 6,652,458 - Blazey , et al. November 25, 2
2003-11-25
Method for assessing cortical response to blue light
Grant 6,630,127 - Renshaw , et al. October 7, 2
2003-10-07
Two-dimensional MR spectroscopy techniques
Grant 6,617,169 - Ke , et al. September 9, 2
2003-09-09
Flupirtine in the treatment of fibromyalgia and related conditions
Grant 6,610,324 - Stoll August 26, 2
2003-08-26
Magnetic field stimulation techniques
Grant 6,572,528 - Rohan , et al. June 3, 2
2003-06-03
Treatment of depression with kappa receptor antagonists
Grant 6,528,518 - Carlezon, Jr. March 4, 2
2003-03-04
Methods for diagnosing Alzheimer's disease and other forms of dementia
Grant 6,475,161 - Teicher , et al. November 5, 2
2002-11-05
Method and apparatus for detecting mental disorders
Grant 6,400,978 - Teicher , et al. June 4, 2
2002-06-04
Method of diagnosing Alzheimer's disease
Grant 6,130,048 - Nixon October 10, 2
2000-10-10
Phased array echoplanar imaging system for fMRI
Grant 6,104,943 - Frederick , et al. August 15, 2
2000-08-15
Cloning and expression of .beta.APP-C100 receptor (C100-R)
Grant 6,083,713 - Manly , et al. July 4, 2
2000-07-04
Use of presenilin-1 for diagnosis of alzheimers disease
Grant 5,985,581 - Nixon , et al. November 16, 1
1999-11-16
Diagnostic assays for Alzheimer's disease
Grant 5,849,600 - Nixon , et al. December 15, 1
1998-12-15
Registration of image data
Grant 5,850,486 - Maas, III , et al. December 15, 1
1998-12-15
Method for treating pain and brain perfusion abnormalities using mixed opioid agonist-antagonists
Grant 5,552,406 - Mendelson , et al. September 3, 1
1996-09-03
In vitro method for screening for drugs that inhibit production or degradation of human A4-amyloid
Grant 5,547,841 - Marotta , et al. August 20, 1
1996-08-20
Multiple antigen immunoassay
Grant 5,149,626 - Fleming September 22, 1
1992-09-22
Treatment for cocaine abuse
Grant 5,075,341 - Mendelson , et al. December 24, 1
1991-12-24
GABA esters and GABA analog esters
Grant 5,051,448 - Shashoua September 24, 1
1991-09-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed